ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Alzheimer Disease

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

COVID-19

Cannabis

Case Discussions

Child & Adolescent Psychiatry

Climate Change

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Digital Therapeutics

Diversity, Equity, Inclusion

Drug Watch

Eating Disorders

Emergency Psychiatry

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Media & Psychiatry

Mental Health Awareness Month

Mood Disorders

Cognitive Disorders

Dementia

Autism

Neuropsychiatry

PTSD

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Postpartum Depression

Psychedelics

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Sports Psychiatry

Suicide

Tardive Dyskinesia

Technology & Psychiatry

Transcranial Magnetic Stimulation

News

Media

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Clinical Case Collective

Dialogues

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Clinical Consult

Clinical Scales

Interactive Tools

Partner Perspectives

Quizzes

Series

Special Reports

Subscribe

Articles

This critical analysis of recent ADHD coverage challenges misconceptions about treatment, emphasizing the need for a comprehensive approach to mental health.

The New York Times Moves the Goalposts on ADHD

 is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, 

; Voluntary Consulting Psychiatrist at Seacoast Mental Health Center, Exeter/Portsmouth, NH; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.

The therapeutic alliance in psychiatry: enhancing patient engagement and treatment outcomes through effective communication and collaboration.

The Therapeutic Alliance

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry and is now in retirement and retirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He presented the third Rabbi Jeffrey B. Stiffman lecture at Congregation Shaare Emeth in St. Louis on Sunday, May 19, 2024. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

 The Eastern Religions, and Spirituality

Check out this reflective analysis of a notable graduation speech and its personal implications.

I’m Like Who?

Learn more about the latest advancements in schizophrenia treatment and the ongoing battle against stigma during Mental Health Awareness Month.

The Dawn of a New Era for Schizophrenia

About

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Facebook

LinkedIn

Spotlight

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales from the New Asylum

1rem

View

Prevalence of Treatment-Resistant Depression

IV Ketamine for Treatment-Resistant Depression

Current Guidelines for Managing Treatment-Resistant Depression

Intranasal Esketamine for Treatment-Resistant Depression

Esketamine for Treatment-Resistant Depression: Patient Selection Criteria

Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression

Response to Esketamine Therapy for Treatment-Resistant Depression

REMS Safety Program for Esketamine in Treatment-Resistant Depression

Treatment-Resistant Depression: Administering Esketamine to Patients

Getting Certified to Administer Esketamine for Treatment-Resistant Depression

Incorporating Esketamine into Practice for Treatment-Resistant Depression

Treatment-Resistant Depression: Financial Support for Esketamine Therapy

Frontline Psychotherapy for Depression

Traditional Classes of Antidepressant Therapies

Electroconvulsive Therapy for Depression

Integrated Care and Treatment-Resistant Depression

Evolving Management Strategies for Treatment-Resistant Depression